Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ FDA chief urges to investigate agency’s relationship with Biogen, maker of controversial new Alzheimer’s drug

FDA chief urges to investigate agency’s relationship with Biogen, maker of controversial new Alzheimer’s drug



FDA acting commissioner Janet Woodcock acknowledged in a letter to Christi A. Grimm, acting director general of the Department of Health and Human Services, that there has been “considerable attention and controversy” regarding the approval of Aduhelm, which is manufactured by Biogen, a biotech company. in Cambridge, Massachusetts. In particular, she said concerns continued to be raised about the agency’s contacts with Biogen, including “some that may have taken place outside the formal correspondence process.”

;


Source link